Susan Altschuller

Chief Financial Officer, ImmunoGen Inc.

Companies

Climb Bio, Inc.Chief financial officer Oct 1, 2025 to now¹
Mural Oncology plcBoard member Nov 7, 2023 to now²
Cerevel Therapeutics Holdings, Inc.Chief financial officer May 19, 2023 to Aug 5, 2024³
ImmunoGen Inc.Chief financial officer Jul 22, 2020 to Dec 27, 2022⁴

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Cerevel Therapeutics Holdings, Inc.0 shares⁵Aug 1, 2024
Mural Oncology plc10,000 shares⁶Aug 14, 2024

As of each latest filing. The line shows shares held over time.

Recent filings

Aug 14, 2024Bought 10,000 shares at $3.21 of Mural Oncology plc⁶
Aug 1, 2024Returned to company 16,913 shares of Cerevel Therapeutics Holdings, Inc.⁵
Dec 20, 2023Sold 13,808 shares at $41.42 of Cerevel Therapeutics Holdings, Inc.⁷
Dec 19, 2023Exercised options 30,721 shares of Cerevel Therapeutics Holdings, Inc.⁷

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARClimb Bio, Inc., Chief financial officer
2
SEC EDGARMural Oncology plc, Board member
3
SEC EDGARCerevel Therapeutics Holdings, Inc., Chief financial officer
4
SEC EDGARImmunoGen Inc., Chief financial officer
5
SEC EDGARCerevel Therapeutics Holdings, Inc. shares after the filing of Aug 1, 2024
6
SEC EDGARMural Oncology plc shares after the filing of Aug 14, 2024
7
SEC EDGARForm 4 filed Dec 21, 2023